While MPDs share some features with cancer, such as uncontrolled cell proliferation, they typically have a more indolent course compared to acute leukemias. However, certain MPDs have the potential to transform into acute myeloid leukemia (AML), a more aggressive form of blood cancer. The risk of transformation varies among different MPDs, with myelofibrosis having a higher likelihood of progression to AML.
